Cell Source, Inc. (CLCS) has a market capitalization of $40.53M and trades at $0.90. The 52-week range is 0.1819-2.25.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of -6, Earnings Per Share (EPS) of $-0.15.
The stock has a beta of -157.98, operates in the Healthcare sector.
